BNO 5.26% 20.0¢ bionomics limited

Ann: Commencement of BNC210 Phase 2 Agitation Trial, page-8

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 707 Posts.
    lightbulb Created with Sketch. 78
    Maybe the follow-up trial should be on agitated shareholders in their own homes,and the negative behavioral effects on other family members!

    That trial could then be widened to workplaces and the effects that sufferers have on other shareholders and board members.

    Huge unmet clinical need!!!

    Ha!!!

    Only joking..........
 
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.